| Name | VEGFR-2-IN-21 |
|---|---|
| Synonyms | Benzenesulfonamide, 4-[2-[4-(7-chloro-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazin-5-yl)phenyl]diazenyl]-N-(4,6-dimethyl-2-pyrimidinyl) |
| Description | VEGFR-2-IN-21 (Compound 5d) is a potent VEGFR-2 inhibitor with an IC50 of 0.10 μM. VEGFR-2-IN-21 shows anticancer activity[1]. |
|---|---|
| Related Catalog | |
| Target |
VEGFR-2:0.10 μM (IC50) |
| In Vitro | VEGFR-2-IN-21 (Compound 5d) shows inhibitory activities against the three HepG2, HCT116 and MCF-7 cancer cell lines with IC50 values of 8.98 ± 0.1, 7.77 ± 0.1 and 6.99 ± 0.1 µM respectively[1]. |
| References |
| Molecular Formula | C28H24ClN7O3S |
|---|---|
| Molecular Weight | 574.05 |